ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NSCI Netscientific Plc

63.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 63.00 61.00 65.00 63.00 63.00 63.00 14,893 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1312 -4.80 14.85M

NetScientific PLC Appointment to the Board (6157P)

14/10/2019 7:00am

UK Regulatory


Netscientific (LSE:NSCI)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Netscientific Charts.

TIDMNSCI

RNS Number : 6157P

NetScientific PLC

14 October 2019

NetScientific plc

("NetScientific" or the "Company")

Appointment to the Board

London, UK - 14 October 2019 - NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, is pleased to announce that Dr. Ilian Iliev will join the Board with immediate effect as a non-executive director.

Ilian founded EMV Capital Limited, a London-based international VC investor, focused on B2B companies in industrial high-tech, energy, smart cities, transportation and healthtech. The firm's investment model is to de-risk technologically complex investments through industrial partnerships with some of the world's leading corporations, as well as attracting financial investors to its portfolio companies. EMV Capital Limited is a spin-out from EcoMachines Ventures Limited, which was founded by Ilian in 2013.

Ilian holds a PhD from Cambridge University's Judge Business School, MCom in Economics and BA in Politics, Economics and International Relations from the University of Witwatersrand. He is also an Associate Fellow at Chatham House, focused on energy and resource efficiency.

Dr. Ilian Petkov Iliev (aged 44) currently holds or has held in the past 5 years the following directorships and partnerships:

 
 Current directorships                Past Directorships & Partnerships 
 EMV Capital Limited                  EcoMachines Ventures Limited 
 Q-Bot Limited                        Autorose Limited 
 Sofant Technologies Limited          Power Drive Efficiency Limited 
 Pointgrab, Inc. (Israel)             Recycling Technologies Limited 
 Wanda Health, Inc. (USA)             Pulsar Capital Solutions 
                                       Limited 
 Vortex Biosciences, Inc. (USA)       Rotary EcoMachines Limited 
 Cambridge Intellectual Property      DiagnovIS Limited 
  Limited 
 Satipimpex (South Africa) 
 Zoom Growth Investments Limited 
 London Innovation Partners Limited 
  Deeptech Growth Investments 
  Limited 
  Futura Messis Group Limited 
  BusiPro O.O.D. (Bulgaria) 
 

In addition, Dr Iliev was a director of Stratpol Advisory Services Limited, which entered into a voluntary arrangement with its creditors in February 2010. The deficit to creditors was GBP22,231.98.

No further disclosure is required under Paragraph (g) to Schedule Two of the AIM Rules for Companies.

Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said:

"We welcome Ilian to the board of NetScientific and look forward to his contribution to the Board."

For more information, please contact:

 
  NetScientific                         Tel: +44 (0)20 3514 1800 
   Ian Postlethwaite, CEO / CFO 
 
  WHIreland (NOMAD, Financial Adviser   Tel: +44 (0)20 7220 1666 
   and Broker) 
   Chris Fielding / Darshan Patel 
 
  MO PR ADVISORY (Press Contact)        Tel: +44 (0)78 7644 4977 
   Mo Noonan 
 

About NetScientific

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.

For more information, please visit the website at www.NetScientific.net

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOAUARKRKAARARA

(END) Dow Jones Newswires

October 14, 2019 02:00 ET (06:00 GMT)

1 Year Netscientific Chart

1 Year Netscientific Chart

1 Month Netscientific Chart

1 Month Netscientific Chart

Your Recent History

Delayed Upgrade Clock